v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 74,317 $ 60,698
Short-term investments 184,792 248,933
Restricted cash - short-term 194 194
Prepaid expenses and other current assets 13,689 11,664
Total current assets 272,992 321,489
Property and equipment, net 54,176 68,576
Operating lease assets 14,007 0
Restricted cash - long-term 1,200 1,200
Other assets 567 574
Total assets 342,942 391,839
Current liabilities:    
Accounts payable 7,963 3,719
Accrued compensation 14,706 10,636
Accrued research and development expenses 8,341 19,210
Other current liabilities 5,733 6,414
Total current liabilities 36,743 39,979
Operating lease liabilities - long-term 14,136 0
Other long-term liabilities 1,282 13,003
Total liabilities 52,161 52,982
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Common stock—$0.0001 par value, 500,000 shares authorized as of December 31, 2019 and 2018, respectively; 56,806 and 45,951 shares issued and outstanding as of December 31, 2019 and 2018, respectively 6 5
Additional paid-in capital 1,108,516 866,541
Accumulated other comprehensive income (loss) 220 (340)
Accumulated deficit (817,961) (527,349)
Total stockholders’ equity 290,781 338,857
Total liabilities and stockholders’ equity $ 342,942 $ 391,839

Source